Connor, Clark & Lunn Investment Management Ltd.
Position in IMVT — Immunovant, Inc.
CIK 1596800
VANCOUVER, A1
Position in IMVT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,262,603
+$5,751,366 QoQ
Shares Held
473,984
-5.9% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#34
of 226 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. IMVT ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in IMVT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,262,603 | 473,984 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,511,237 | 503,673 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,883,061 | 467,469 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,009,419 | 558,897 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,176,240 | 448,515 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,224,673 | 364,229 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,842,846 | 235,884 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,183,089 | 181,799 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,298,723 | 238,588 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,665,079 | 144,385 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,329,611 | 150,240 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,489,316 | 247,182 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,803,841 | 147,804 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $967,560 | 62,383 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $465,387 | 26,219 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $102,404 | 18,352 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $246,120 | 44,668 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,320,949 | 155,041 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $678,263 | 78,051 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||